Monocyte chemoattractant protein-1 promoter -2518 polymorphism is associated with post-challenge insulin and glucose levels in non-diabetic Japanese subjects

Diabetes Research and Clinical Practice

Volumn 78, Issue 2, 2007, Pages 208-210

  Maruyama Furuta, Noriko ^a   Yano, Yutaka ^a   Gabazza, Esteban C ^a   Suematsu, Mina ^a   Matsumoto, Kazutaka ^a   Akatsuka, Hajime ^a   Bruno, Nelson E ^a   Araki, Rika ^b   Katsuki, Akira ^a   Sumida, Yasuhiro ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE NATIONAL HOSPITAL   (Japan)

Author keywords

Insulin resistance; MCP 1; OGTT; Polymorphism

Indexed keywords

GLUCOSE; INSULIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; JAPANESE; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CHEMOKINE CCL2; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; JAPAN; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 34548838811     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.03.017     Document Type: Article

References (13)

1. Piemonti L., Leone B.E., Nano R., Saccani A., Monti P., Maffi P., et al. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 51 (2002) 55-65
2. Bai Y., Robinson E., Chai R., Ross J.M., and Reddy S. Immunohistochemical study of monocyte chemoattractant protein-1 in the pancreas of NOD mice following cyclophosphamide administration and during spontaneous diabetes. J. Mol. Histol. 37 (2006) 101-113
3. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116 (2006) 1494-1505
4. Kamei N., Tobe K., Suzuki R., Ohsugi M., Watanabe T., Kubota N., et al. Overexpression of MCP-1 in adipose tissues causes macrophage recruitment and insulin resistance. J. Biol. Chem. 281 (2006) 26602-26614
5. Sartipy P., and Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 7265-7270
6. Rovin B.H., Lu L., and Saxena R.A. Novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem. Biophys. Res. Commun. 259 (1999) 344-348
7. Yang B., Houlber K., Millward A., and Demaine A. Polymorphisms of chemokine and chemokine receptor genes in Type 1 diabetes mellitus and its complications. Cytokine 26 (2004) 114-121
8. Simeoni E., Hoffmann M.M., Winkelmann B.R., Ruiz J., Fleury S., Boehm B.O., et al. Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. Diabetologia 47 (2004) 1574-1580
9. Zietz B., Büchler C., Herfarth H., Müller-Ladner U., Spiegel D., Schölmerich J., et al. Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A → G promoter polymorphism. Diabetes Obes. Metab. 7 (2005) 570-578
10. Nishimura M., Kuno S., Mizuta I., Ohta M., Maruyama H., Kaji R., et al. Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease. Mov. Disord. 18 (2003) 953-955
11. Gutt M., Davis C.L., Spitzer S.B., Llabre M.M., Kumar M., Czarnecki E.M., et al. Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res. Clin. Pract. 47 (2000) 177-184
12. Stumvoll M., Mitrakou A., Pimenta W., Jenssen T., Yki-Jarvinen H., Van Haeften T., et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23 (2000) 295-301
13. Hanley A.J., Williams K., Gonzalez C., D'Agostino Jr. R.B., Wagenknecht L.E., Stern M.P., et al. San Antonio Heart Study; Mexico City Diabetes Study; Insulin Resistance Atherosclerosis Study, Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 52 (2003) 463-469